<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>NISCAIR Online Periodicals Repository Collection: IJEB Vol.44(07) [July 2006]</title>
    <link>http://nopr.niscair.res.in/handle/123456789/6428</link>
    <description />
    <textInput>
      <title>The Collection's search engine</title>
      <description>Search the Channel</description>
      <name>search</name>
      <link>http://nopr.niscair.res.in/simple-search</link>
    </textInput>
    <item>
      <title>Molecular characterization of mutation associated with rifampicin and isoniazid resistance in &lt;i style=""&gt;Mycobacterium tuberculosis&lt;/i&gt; isolates</title>
      <link>http://nopr.niscair.res.in/handle/123456789/6548</link>
      <description>Title: Molecular characterization of mutation associated with rifampicin and isoniazid resistance in &lt;i style=""&gt;Mycobacterium tuberculosis&lt;/i&gt; isolates
&lt;br/&gt;
&lt;br/&gt;Authors: Negi, Sanjay Singh; Anand, Ranjana; Pasha, S T; Gupta, Sunil; Basir, Seemi Farhat; Khare, Shashi; Lal, Shiv
&lt;br/&gt;
&lt;br/&gt;Abstract: Nucleotide changes in catalase peroxidase (&lt;i style=""&gt;Kat G&lt;/i&gt;) gene and gene encoding the beta&#xD;
subunit of RNA polymerase (&lt;i style=""&gt;rpo B&lt;/i&gt;),&#xD;
responsible for isoniazid and rifampicin drug resistance were determined in the&#xD;
clinical isolates of &lt;i style=""&gt;Mycobacterium&#xD;
tuberculosis&lt;/i&gt; by PCR-RFLP, Line probe assay and DNA sequencing.&lt;b style=""&gt; &lt;/b&gt;PCR-RFLP test was performed by HapII&#xD;
cleavage of an amplified fragment of &lt;i style=""&gt;Kat&#xD;
G&lt;/i&gt; gene to detect the transversion&lt;b style=""&gt; &lt;/b&gt;315AGC→ACC(Ser→Thr)&#xD;
which is associated with INH drug resistance. The Line probe assay kit was&#xD;
evaluated to detect the mutation in 81bp RMP resistance determining region of &lt;i style=""&gt;rpo B&lt;/i&gt; gene associated with RMP drug&#xD;
resistance. These results were validated by DNA sequencing and drug&#xD;
susceptibility test.&lt;b style=""&gt; &lt;/b&gt;&lt;i style=""&gt;Kat G&lt;/i&gt; S 315 T mutation was found in&#xD;
74.19% strains of &lt;i style=""&gt;M. tuberculosis&lt;/i&gt;&#xD;
from Delhi. This mutation was not found in any of the susceptible strains&#xD;
tested. The line probe assay kit&lt;b style=""&gt; &lt;/b&gt;and&#xD;
DNA sequencing identified 18&lt;b style=""&gt; &lt;/b&gt;isolates&#xD;
as RMP&lt;b style=""&gt; &lt;/b&gt;resistant&lt;b style=""&gt; &lt;/b&gt;with specific mutation,&lt;b style=""&gt; &lt;/b&gt;while&#xD;
one of the RMP resistant strain was identified as RMP susceptible, with a&#xD;
concordance of 94.73% with the&lt;b style=""&gt; &lt;/b&gt;phenotypic&#xD;
drug susceptibility result.&lt;b style=""&gt; &lt;/b&gt;Majority&#xD;
(8 of 19, 42.1%) of resistant isolates involved base changes at codon 531 of&lt;b style=""&gt; &lt;/b&gt;&lt;i style=""&gt;rpo&#xD;
B&lt;/i&gt; gene.&lt;b style=""&gt; &lt;/b&gt;Both PCR-RFLP and Line&#xD;
probe assay test can be used in many of the clinical microbiology laboratories&#xD;
for early detection of isoniazid and rifampicin drug resistance in clinical&#xD;
isolates of &lt;i style=""&gt;M. tuberculosis&lt;/i&gt;.
&lt;br/&gt;
&lt;br/&gt;Page(s): 547-553</description>
      <pubDate>Wed, 28 Jun 2006 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>Erythrocyte antioxidant enzymes in toxicological evaluation of commonly used organophosphate pesticides</title>
      <link>http://nopr.niscair.res.in/handle/123456789/6547</link>
      <description>Title: Erythrocyte antioxidant enzymes in toxicological evaluation of commonly used organophosphate pesticides
&lt;br/&gt;
&lt;br/&gt;Authors: Singh, Mohan; Sandhir, Rajat; Kiran, Ravi
&lt;br/&gt;
&lt;br/&gt;Abstract: Erythrocytes&#xD;
are excellent models for the study of interactions of xenobiotics with&#xD;
biomembranes. Present work is designed to study the &lt;i style=""&gt;in vitro&lt;/i&gt; effects of some organophosphates (ethion, chlorpyrifos,&#xD;
dimethoate and monocrotophos) on rat erythrocytes. Treatment of erythrocytes&#xD;
with organophosphates resulted in decreased erythrocyte glucose-6-phosphate&#xD;
dehydrogenase (G-6-PD) activity, whereas activities of&#xD;
glutathione-s-transferase (GST) and glutathione reductase (GR) were increased.&#xD;
Reduced Glutathione (GSH) content of RBCs was decreased after treatment with&#xD;
the pesticides. Increased activities of GST and GR were due to induction of&#xD;
natural defense mechanism of erythrocytes against the toxicity of the&#xD;
pesticides. Membrane bound enzymes like acetylcholinesterase (AChE), Na&lt;sup&gt;+&lt;/sup&gt;-K&lt;sup&gt;+&lt;/sup&gt;-ATPase&#xD;
and Ca&lt;sup&gt;2+&lt;/sup&gt;-ATPase were also inhibited. Altered activities of these&#xD;
enzymes along with decreased GSH content indicate increased oxidative stress in&#xD;
erythrocytes after treatment with organophosphates
&lt;br/&gt;
&lt;br/&gt;Page(s): 580-583</description>
      <pubDate>Wed, 28 Jun 2006 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>Teratogenicity of &lt;i style=""&gt;Asparagus racemosus&lt;/i&gt; Willd. root, a herbal medicine</title>
      <link>http://nopr.niscair.res.in/handle/123456789/6546</link>
      <description>Title: Teratogenicity of &lt;i style=""&gt;Asparagus racemosus&lt;/i&gt; Willd. root, a herbal medicine
&lt;br/&gt;
&lt;br/&gt;Authors: Goel, R K; Prabha, T; Kumar, M Mohan; Dorababu, M; Prakash; Singh, G
&lt;br/&gt;
&lt;br/&gt;Abstract: &lt;i style=""&gt;Asparagus racemosus&lt;/i&gt; (AR) is a herb used as a rasayana in Ayurveda&#xD;
and is considered both general and female reproductive tonic. Methanolic&#xD;
extract of &lt;i style=""&gt;A. racemosus&lt;/i&gt; roots (ARM;&#xD;
100 mg/kg/day for 60 days) showed teratological disorders in terms of increased&#xD;
resorption of fetuses, gross malformations e.g. swelling in legs and&#xD;
intrauterine growth retardation with a small placental size in Charles Foster&#xD;
rats. Pups born to mother exposed to ARM for full duration of gestation showed&#xD;
evidence of higher rate of resorption and therefore smaller litter size. The&#xD;
live pup showed significant decrease in body weight and length and delay of&#xD;
various developmental parameters when compared to respective control groups. AR&#xD;
therefore, should be used in pregnancy cautiously as its exposure during that&#xD;
period may cause damage to the offspring.
&lt;br/&gt;
&lt;br/&gt;Page(s): 570-573</description>
      <pubDate>Wed, 28 Jun 2006 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>A comparative study on the protective effects of 17β-estradiol, biochanin A and bisphenol A on mammary gland differentiation and tumorigenesis in rats</title>
      <link>http://nopr.niscair.res.in/handle/123456789/6545</link>
      <description>Title: A comparative study on the protective effects of 17β-estradiol, biochanin A and bisphenol A on mammary gland differentiation and tumorigenesis in rats
&lt;br/&gt;
&lt;br/&gt;Authors: Yin, Hong; Ito, Akihiro; Bhattacharjee, Dilip; Hoshi, Masaharu
&lt;br/&gt;
&lt;br/&gt;Abstract: Mammary tissue differentiation and tumorigenesis were&#xD;
studied in female rats following subcutaneous injection at 2, 4 and 6 days&#xD;
after birth with low or high doses of 17β-estradiol (0.1&#xD;
or 10 µg; E2), biochanin A (0.1 or&#xD;
10 mg; BCA) or bisphenol A (0.1 or 10.0 mg; BPA). Half of the rats were killed on day 35 to analyze the&#xD;
terminal end bud (TEB), terminal duct (TD) and alveolar bud (AB) of the mammary&#xD;
tissue. The remaining rats were injected, ip, with a dose of 50 mg/kg of &#xD;
N-nitroso-N-methylurea (MNU) at 7 weeks of age and sacrificed 26 weeks later.&#xD;
The incidence and multiplicity of mammary tumors (MT) decreased among all three&#xD;
different treated groups, dose-dependently. However, the pattern of mammary&#xD;
gland differentiation varied. No significant difference was observed after E2 administration.&#xD;
TEB decreased dose-dependently in BCA treated groups and the number of TD and&#xD;
AB were suppressed significantly in BPA high dose group.
&lt;br/&gt;
&lt;br/&gt;Page(s): 540-546</description>
      <pubDate>Wed, 28 Jun 2006 22:58:59 GMT</pubDate>
    </item>
  </channel>
</rss>

